Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
15.99
+0.55 (3.56%)
At close: Mar 9, 2026, 4:00 PM EDT
16.30
+0.31 (1.94%)
After-hours: Mar 9, 2026, 5:59 PM EDT
Pharming Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,081 | 650 | 763 | 756 | 572 | 993 | |
| Market Cap Growth | 69.52% | -14.84% | 0.93% | 32.18% | -42.41% | -10.20% | |
| Enterprise Value | 1,046 | 608 | 728 | 702 | 554 | 963 | |
| Last Close Price | 15.99 | 10.06 | 11.43 | 11.03 | 8.94 | 15.20 | |
| PE Ratio | 2829.89 | - | - | 55.27 | 35.75 | 26.30 | |
| PS Ratio | 2.98 | 2.19 | 3.11 | 3.68 | 2.88 | 4.68 | |
| PB Ratio | 4.08 | 2.94 | 3.49 | 3.69 | 2.96 | 5.41 | |
| P/TBV Ratio | 8.33 | 4.06 | 5.17 | 5.82 | 5.23 | 10.47 | |
| P/FCF Ratio | 20.50 | - | - | 35.85 | 21.10 | 12.57 | |
| P/OCF Ratio | 20.27 | - | - | 33.66 | 15.11 | 11.87 | |
| EV/Sales Ratio | 2.89 | 2.05 | 2.97 | 3.41 | 2.78 | 4.54 | |
| EV/EBITDA Ratio | 21.83 | 188.69 | - | 40.97 | 18.22 | 11.66 | |
| EV/EBIT Ratio | 25.24 | - | - | 67.70 | 23.07 | 12.62 | |
| EV/FCF Ratio | 19.84 | - | - | 33.29 | 20.43 | 12.19 | |
| Debt / Equity Ratio | 0.50 | 0.51 | 0.78 | 0.82 | 0.84 | 0.88 | |
| Debt / EBITDA Ratio | 2.55 | 17.02 | - | 8.46 | 4.88 | 1.92 | |
| Debt / FCF Ratio | 2.48 | - | - | 7.91 | 5.97 | 2.05 | |
| Net Debt / Equity Ratio | -0.13 | -0.25 | -0.19 | -0.20 | -0.16 | -0.24 | |
| Net Debt / EBITDA Ratio | -0.74 | -17.24 | 2.74 | -2.37 | -0.99 | -0.52 | |
| Net Debt / FCF Ratio | -0.67 | 21.50 | 2.24 | -1.93 | -1.11 | -0.55 | |
| Asset Turnover | 0.81 | 0.69 | 0.55 | 0.50 | 0.49 | 0.63 | |
| Inventory Turnover | 0.57 | 0.63 | 0.51 | 0.50 | 0.87 | 1.26 | |
| Quick Ratio | 2.39 | 2.96 | 3.28 | 3.90 | 4.69 | 3.09 | |
| Current Ratio | 3.16 | 3.77 | 4.06 | 4.65 | 5.33 | 3.43 | |
| Return on Equity (ROE) | 0.03% | -5.38% | -4.98% | 6.88% | 8.50% | 25.09% | |
| Return on Assets (ROA) | 5.76% | -0.52% | -3.06% | 1.57% | 3.68% | 14.13% | |
| Return on Invested Capital (ROIC) | 0.08% | -2.10% | -12.76% | 5.79% | 10.98% | 54.07% | |
| Return on Capital Employed (ROCE) | 10.70% | -1.10% | -5.70% | 2.80% | 6.80% | 22.30% | |
| Earnings Yield | 0.04% | -1.82% | -1.38% | 1.81% | 2.80% | 3.80% | |
| FCF Yield | 4.88% | -0.40% | -2.46% | 2.79% | 4.74% | 7.95% | |
| Buyback Yield / Dilution | 2.65% | -2.18% | 7.09% | -0.85% | -2.70% | -1.37% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.